-
Neil Sedaka, US singer and songwriter, dies age 86
-
Paramount acquires Warner Bros. in $110 bn mega-merger
-
Rosenior eyes extended stay to stabilise Chelsea
-
Spurs struggling physically admits Tudor
-
Lens held by Strasbourg in blow to Ligue 1 title chances
-
NFL salary cap passes $300 mn for first time
-
Wolves secure rare win to dent Villa's bid for Champions League place
-
Oil prices jump on Iran attack fears while US stocks fall
-
Two dead, dozens injured as tram derails in Milan
-
Trump tells US govt to 'immediately' stop using Anthropic AI tech
-
Court orders Greenpeace to pay $345 mn to US oil pipeline company
-
IAEA stresses 'urgency' to verify Iran's nuclear material
-
UN urges action to prevent full civil war in South Sudan
-
Hackers steal medical details of 15 million in France
-
Susan Sarandon praises Spain’s stance on Gaza
-
Murray adamant size isn't everything despite losing Wales place
-
Messi knocked down by fan in Puerto Rico pitch invasion
-
Two killed, dozens injured as tram derails in Milan
-
O'Neill taken aback by Rangers boss Rohl's comments on Celtic
-
Ukrainian, Slovak leaders hold call amid energy spat
-
French hard-left firebrand sparks row with 'antisemitic' Epstein jibe
-
Ahmed, Jacks blast England to thrilling win over New Zealand
-
UK police arrest man after Churchill statue sprayed with graffiti
-
Bill Clinton denies wrongdoing at grilling on Epstein ties
-
Red Cross urges Afghanistan-Pakistan 'de-escalation'
-
Coup role revelations revive calls for return of Spain's ex king
-
Oil prices jump on Iran attack fears, Wall Street slips on AI
-
TikTok disinformation: the other weapon in Mexico violence
-
Carmaker BMW to trial humanoid robots at German factory
-
NASA announces overhaul of Artemis lunar program amid technical delays
-
Golfer Pavan undergoes surgery after freak lift fall
-
Bill Clinton faces grilling on extensive ties to Epstein
-
For Roberto Cavalli designer, dreams come in all black
-
Macron to set out how France's nuclear arms could protect Europe
-
Spin-heavy England restrict New Zealand to 159-7 in Super Eights
-
Starmer vows to fight 'extremes' after UK Labour election drubbing
-
New Pokemon titles on horizon as 30th anniversary approaches
-
Arteta backs Gyokeres to impact Arsenal's trophy charge
-
55 Ghanaians killed after being lured into Ukraine war: govt
-
OpenAI raises $110 bn in record funding round
-
Medvedev swats Auger-Aliassime aside to reach Dubai final
-
Stocks slide, oil jumps tracking AI and Iran
-
France warns of 'provocation' if Russian drone buzzed aircraft carrier
-
At Milan Fashion Week, industry's darker side goes unmentioned
-
'Impressive' Maguire has Man Utd future says Carrick
-
'Games you live for': Rosenior relishes Chelsea's PSG tie
-
'Sacrificed futures': German chemical workers protest looming job cuts
-
Scientists discover giant bird-like dinosaur in Niger desert
-
Pakistan promise final flourish as they await T20 World Cup fate
-
Kurdish Iranian groups in Iraq eye opportunity for change at home
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
H.Silva--PC